CAM
NUVB icon

Cresset Asset Management’s Nuvation Bio NUVB Stock Holding History

Cresset Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$519K Buy
121,040
+2,400
+2% +$13.4K ﹤0.01% 1049
2025
Q4 		$1.06M Sell
118,640
-25,050
-17% -$155K ﹤0.01% 768
2025
Q3 		$532K Hold
143,690
– – ﹤0.01% 1001
2025
Q2 		$280K Buy
143,690
+4,874
+4% +$10.2K ﹤0.01% 1158
2025
Q1 		$244K Buy
138,816
+2,381
+2% +$5.42K ﹤0.01% 1431
2024
Q4 		$363K Buy
136,435
+2,145
+2% +$5.52K ﹤0.01% 1246
2024
Q3 		$308K Buy
134,290
+7,140
+6% +$21.8K ﹤0.01% 1789
2024
Q2 		$371K Hold
127,150
– – ﹤0.01% 1599
2024
Q1 		$463K Buy
127,150
+100
+0.1% +$192 ﹤0.01% 1368
2023
Q4 		$192K Sell
127,050
-1,163
-0.9% -$1.5K ﹤0.01% 1699
2023
Q3 		$172K Sell
128,213
-640
-0.5% -$1.06K ﹤0.01% 1653
2023
Q2 		$232K Buy
128,853
+1,703
+1% +$2.9K ﹤0.01% 1664
2023
Q1 		$211K Hold
127,150
– – ﹤0.01% 733
2022
Q4 		$244K Sell
127,150
-68,900
-35% -$139K ﹤0.01% 591
2022
Q3 		$440K Hold
196,050
– – 0.01% 548
2022
Q2 		$636K Hold
196,050
– – 0.01% 490
2022
Q1 		$1.03M Hold
196,050
– – 0.01% 401
2021
Q4 		$1.67M Buy
196,050
+9,000
+5% +$82.7K 0.02% 328
2021
Q3 		$1.86M Hold
187,050
– – 0.03% 245
2021
Q2 		$1.74M Buy
187,050
+60,000
+47% +$684K 0.02% 232
2021
Q1 		$1.33M Buy
+127,050
New +$1.42M 0.02% 233

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cresset Asset Management's NUVB Position: Q1 2026 in Review

Cresset Asset Management increased its Nuvation Bio (NUVB) stake by 2% in Q1 2026, buying an estimated $13.4K and bringing the position to 121,040 shares worth $519K. The position accounts for ﹤0.01% of the portfolio, ranked #1049.

Cresset Asset Management first reported a position in NUVB in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.86M in Q3 2021. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Cresset Asset Management held 121,040 shares of Nuvation Bio worth $519K as of Q1 2026.
  • Cresset Asset Management bought 2,400 Nuvation Bio shares in Q1 2026, an estimated $13.4K.
  • Nuvation Bio made up ﹤0.01% of Cresset Asset Management's portfolio in Q1 2026, its #1049 holding.
  • Cresset Asset Management first reported a position in Nuvation Bio in Q1 2021 and has held it in 21 quarters since.
  • Cresset Asset Management's Nuvation Bio position peaked at $1.86M in Q3 2021.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Cresset Asset Management's 13F filing for Q1 2026, filed 15 May 2026.